对与帕金森病相关的α-synuclein蛋白变体和翻译后修改的in silico分析
Aloma N R da Silva1, Gabriel R C Pereira1, Luiz Felippe Sarmento Bonet1
1Bioinformatics and Computational Biology Laboratory, Department of Genetics and Molecular Biology, Federal University of the State of Rio de Janeiro (UNIRIO), Rio de Janeiro, Rio de Janeiro, Brazil.
Journal of cellular biochemistry
|January 19, 2024
概括
对α-synuclein (ASYN) 突变的计算分析揭示了与帕金森病 (PD) 发病的潜在联系. 特定的ASYN变异可能会改变蛋白质动态,为PD提供新的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 计算生物学 计算生物学
- 遗传学 是一个遗传学.
背景情况:
- 帕金森病 (PD) 是一种流行的神经退行性疾病,影响全球数百万人.
- 阿尔法-同核素 (ASYN) 蛋白质聚合到莱维体中是PD的关键病理标志.
- 在ASYN中发生的突变和翻译后修改 (PTM) 与PD病变发生有关.
研究的目的:
- 通过计算来描述ASYN误解突变和PTM对蛋白质结构和功能的影响.
- 为了识别特定的ASYN变异和可能导致PD的保留地点.
- 阐明在PD中ASYN聚合背后的分子机制.
主要方法:
- 从文献和数据库中编译和预测分析了ASYN中的77个误解突变.
- 使用算法预测ASYN酸化和SUMOylation位点.
- 使用ConSurf. 估计ASYN氨基酸的进化保护.
- 野生类型ASYN和使用GROMACS.选择的变体的分子动力学 (MD) 模拟.
主要成果:
- 大多数分析的ASYN突变并没有显著改变稳定性,聚合性或伴侣结合.
- 然而,许多突变发生在进化保存的地点,并获得了高有害的预测.
- 预测特定突变 (例如,K6N,T22I,K34E) 可能是有害的.
- MD模拟显示了ASYN变体的显著动态变化,可能会损害域互动并促进聚合.
结论:
- 已识别的ASYN突变及其保存性质可能在PD病变发生过程中发挥作用.
- 计算预测突出了具体的变体,以便进一步调查.
- 变体中改变的ASYN动态可能是蛋白质聚合和PD发展的关键因素.
- 这些发现支持未来对帕金森病的ASYN向疗法的研究.
更多相关视频
12:01Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
10.8K
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
10.6K
相关概念视频
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Parkinson's Disease: Overview
551
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
551
